Target Name: TENM3
NCBI ID: G55714
Review Report on TENM3 Target / Biomarker Content of Review Report on TENM3 Target / Biomarker
TENM3
Other Name(s): FLJ10886 | TNM3 | Ten-m3 | Ten-3 | TEN3_HUMAN | Teneurin-3 | protein Odd Oz/ten-m homolog 3 | ODZ3 | tenascin-M3 | testicular tissue protein Li 195 | Protein Odd Oz/ten-m homolog 3 | Teneurin transmembrane protein 3 | Odd Oz/Ten-m homolog 3 | MCOPS15 | KIAA1455 | ten-3 | teneurin transmembrane protein 3 | Tenascin-M3 | MCOPCB9 | odz, odd Oz/ten-m homolog 3 | TEN3 | ODZ3-like protein | FLJ10474 | Odz, odd Oz/ten-m homolog 3

Exploring the Potential Drug Target and Biomarker JNJ-752605: TENM3 (FLJ10886)

The search for new drug targets and biomarkers has become a critical aspect of modern drug development. drug targets are proteins or molecules that are associated with a range of diseases, including cancer, cardiovascular diseases, and neurological disorders. Biomarkers are laboratory or clinical parameters that are used to monitor the progression of a disease or the effectiveness of a treatment. The identification and characterization of potential drug targets and biomarkers is crucial for the development of new treatments that can improve the health and quality of life for patients.

TENM3 (FLJ10886) is a gene that has been identified as a potential drug target and biomarker for various diseases. In this article, we will explore the potential drug target and biomarker associated with TENM3, and the current research being conducted to develop new treatments using this protein.

Potential Drug Target: TENM3 and Its Potential Role in Cancer

TENM3 is a gene that has been shown to be involved in the development and progression of various diseases, including cancer. Several studies have demonstrated that TENM3 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, studies have shown that TENM3 is involved in the regulation of cell signaling pathways that are critical for cancer growth and progression.

One of the key features of TENM3 is its role in the regulation of the PI3K/AKT signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell survival, angiogenesis, and inflammation. TENM3 has been shown to play a critical role in the regulation of this pathway, and is associated with the development and progression of cancer.

In addition to its role in cancer, TENM3 is also being investigated as a potential drug target for treating other diseases. For example, studies have shown that TENM3 is involved in the regulation of inflammation, and that it has anti-inflammatory effects. This suggests that TENM3 may be an effective target for treating diseases that are characterized by inflammation, such as rheumatoid arthritis, lupus, and chronic obstructive pulmonary disease (COPD).

Potential Biomarker: TENM3 as a Potential Blood Biomarker

In addition to its potential role as a drug target, TENM3 is also being investigated as a potential biomarker for cancer. Several studies have shown that TENM3 is expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, studies have shown that TENM3 is involved in the regulation of cell signaling pathways that are critical for cancer growth and progression.

One of the key features of TENM3 as a biomarker is its ability to be detected in blood samples. This makes it an attractive potential biomarker for cancer diagnosis and monitoring. Studies have shown that TENM3 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, studies have shown that TENM3 is involved in the regulation of cell signaling pathways that are critical for cancer growth and progression.

In addition to its potential as a biomarker, TENM3 is also being investigated as a potential drug target for treating cancer. The identification and characterization of potential drug targets and biomarkers is a critical aspect of drug development, and the development of new treatments for cancer will require the continued research and development of new drug targets and biomarkers.

Conclusion

TENM3 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The regulation of the PI3K/AKT signaling pathway is a key feature of TENM3, and its role in the regulation of cell signaling pathways is being further investigated as a potential mechanism

Protein Name: Teneurin Transmembrane Protein 3

Functions: Involved in neural development by regulating the establishment of proper connectivity within the nervous system. Acts in both pre- and postsynaptic neurons in the hippocampus to control the assembly of a precise topographic projection: required in both CA1 and subicular neurons for the precise targeting of proximal CA1 axons to distal subiculum, probably by promoting homophilic cell adhesion. Required for proper dendrite morphogenesis and axon targeting in the vertebrate visual system, thereby playing a key role in the development of the visual pathway. Regulates the formation in ipsilateral retinal mapping to both the dorsal lateral geniculate nucleus (dLGN) and the superior colliculus (SC). May also be involved in the differentiation of the fibroblast-like cells in the superficial layer of mandibular condylar cartilage into chondrocytes

The "TENM3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TENM3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TENM3-AS1 | TENM4 | TENT2 | TENT4A | TENT4B | TENT5A | TENT5B | TENT5C | TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex